Cargando…
Current achievements and future perspectives in whole-organ bioengineering
Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developmen...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450459/ https://www.ncbi.nlm.nih.gov/pubmed/26028404 http://dx.doi.org/10.1186/s13287-015-0089-y |
_version_ | 1782374000633053184 |
---|---|
author | Peloso, Andrea Dhal, Abritee Zambon, Joao P Li, Peng Orlando, Giuseppe Atala, Anthony Soker, Shay |
author_facet | Peloso, Andrea Dhal, Abritee Zambon, Joao P Li, Peng Orlando, Giuseppe Atala, Anthony Soker, Shay |
author_sort | Peloso, Andrea |
collection | PubMed |
description | Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient’s vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ. |
format | Online Article Text |
id | pubmed-4450459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44504592015-06-02 Current achievements and future perspectives in whole-organ bioengineering Peloso, Andrea Dhal, Abritee Zambon, Joao P Li, Peng Orlando, Giuseppe Atala, Anthony Soker, Shay Stem Cell Res Ther Review Irreversible end-stage organ failure represents one of the leading causes of death, and organ transplantation is currently the only curative solution. Donor organ shortage and adverse effects of immunosuppressive regimens are the major limiting factors for this definitive practice. Recent developments in bioengineering and regenerative medicine could provide a solid base for the future creation of implantable, bioengineered organs. Whole-organ detergent-perfusion protocols permit clinicians to gently remove all the cells and at the same time preserve the natural three-dimensional framework of the native organ. Several decellularized organs, including liver, kidney, and pancreas, have been created as a platform for further successful seeding. These scaffolds are composed of organ-specific extracellular matrix that contains growth factors important for cellular growth and function. Macro- and microvascular tree is entirely maintained and can be incorporated in the recipient’s vascular system after the implant. This review will emphasize recent achievements in the whole-organ scaffolds and at the same time underline complications that the scientific community has to resolve before reaching a functional bioengineered organ. BioMed Central 2015-06-01 /pmc/articles/PMC4450459/ /pubmed/26028404 http://dx.doi.org/10.1186/s13287-015-0089-y Text en © Peloso et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Peloso, Andrea Dhal, Abritee Zambon, Joao P Li, Peng Orlando, Giuseppe Atala, Anthony Soker, Shay Current achievements and future perspectives in whole-organ bioengineering |
title | Current achievements and future perspectives in whole-organ bioengineering |
title_full | Current achievements and future perspectives in whole-organ bioengineering |
title_fullStr | Current achievements and future perspectives in whole-organ bioengineering |
title_full_unstemmed | Current achievements and future perspectives in whole-organ bioengineering |
title_short | Current achievements and future perspectives in whole-organ bioengineering |
title_sort | current achievements and future perspectives in whole-organ bioengineering |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450459/ https://www.ncbi.nlm.nih.gov/pubmed/26028404 http://dx.doi.org/10.1186/s13287-015-0089-y |
work_keys_str_mv | AT pelosoandrea currentachievementsandfutureperspectivesinwholeorganbioengineering AT dhalabritee currentachievementsandfutureperspectivesinwholeorganbioengineering AT zambonjoaop currentachievementsandfutureperspectivesinwholeorganbioengineering AT lipeng currentachievementsandfutureperspectivesinwholeorganbioengineering AT orlandogiuseppe currentachievementsandfutureperspectivesinwholeorganbioengineering AT atalaanthony currentachievementsandfutureperspectivesinwholeorganbioengineering AT sokershay currentachievementsandfutureperspectivesinwholeorganbioengineering |